Skip to main content

Sodium Acetate Injection

Last Updated: December 2, 2022
Status: Current

Products Affected - Description
    • Sodium acetate injection, Fresenius Kabi, 4 mEq/mL, 100 mL vial, 20 count, NDC 63323-0032-00
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 100 mL vial, 25 count, NDC 00409-3299-06
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 20 mL vial, 25 count, NDC 00409-7299-73
    • Sodium acetate injection, Pfizer, 2 mEq/mL, 50 mL vial, 25 count, NDC 00409-3299-05
Reason for the Shortage
    • Fresenius Kabi has sodium acetate injection on shortage due to increased demand.
    • Pfizer has sodium acetate injection on shortage due to production delays from a component of a third-party supplier.
    • Woodward Pharma did not provide a reason for the shortage.
Available Products
    • Sodium acetate injection, Woodward, 2 mEq/mL, 100 mL vial, 1 count, NDC 69784-0231-20
    • Sodium acetate injection, Woodward, 2 mEq/mL, 50 mL vial, 1 count, NDC 69784-0230-20

Estimated Resupply Dates

    • Fresenius Kabi has sodium acetate 4 mEq/mL 100 mL vials on back order and the company cannot estimate a release date.
    • Pfizer has sodium acetate 2 mEq/mL 20 mL, 50 mL, and 100 mL vials on back order and the company estimates a release date of January 2023.

Updated

Updated December 2, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created September 1, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.